[
    [
        {
            "time": "",
            "original_text": "医药生物行业2020年中报业绩综述：受疫情影響分化明显，器械、CXO维持高景气",
            "features": {
                "keywords": [
                    "医药生物",
                    "疫情",
                    "器械",
                    "CXO",
                    "高景气"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "器械",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业2020年中报业绩综述：受疫情影響分化明显，器械、CXO维持高景气",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报2020年第35期：板块回调不改行业高景气，关注器械、创新等细分领域发展机会",
            "features": {
                "keywords": [
                    "医药",
                    "板块回调",
                    "高景气",
                    "器械",
                    "创新"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "器械",
                    "创新"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业周报2020年第35期：板块回调不改行业高景气，关注器械、创新等细分领域发展机会",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股普遍强势，国瓷材料、广联达、金域医学、甘李药业领涨",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "国瓷材料",
                    "广联达",
                    "金域医学",
                    "甘李药业"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍强势，国瓷材料、广联达、金域医学、甘李药业领涨",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]